Asia Pacific Medical Device and Diagnostics Contract Research Organization Market Size by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Asia Pacific Medical Device and Diagnostics Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Medical Devices, and Diagnostics) and Services (Clinical Data Management, Monitoring, Clinical Project Management, Medical Writing, Clinical Auditing, Digital Health, Clinical Strategy, and Others)

  • Report Code : TIPRE00024092
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 139
Buy Now

The medical device and diagnostics contract research organization market in APAC is expected to grow from US$ 2,394.72 million in 2021 to US$ 4,110.91 million by 2028; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028.

Australia, China, India, Japan, and South Korea are major economies in APAC. Market consolidation on rise is the major factor driving the growth of the APAC medical device and diagnostics contract research organization market. The CRO services industry is highly fragmented, with several hundred small and medium-sized limited-service providers, and a small number of large and full-service CROs. There are a few barriers for smaller CROs to enter the APAC market. However, the full-service CROs require efficient infrastructure with an ability to simultaneously manage multiple complex testing services across numerous geographies, establish the requisite relationships with strategic partners, and develop relevant therapeutic and expertise to meet the needs of end users. Over the past a few years, the consolidation across the industry is an emerging trend followed by most of the prime players to strengthen their service offerings and garner the major market share in the APAC medical device & diagnostics contract research organization market. For instance, PAREXEL International Corp. acquired The Medical Affairs Company in 2017. This has led to the generation of larger CROs with the wide geographic diversification, extensive therapeutic and development expertise, enormous capital and technical resources to manage the demanding drug development programs, medical device designing and research as well as management of regulatory affairs for pharmaceutical and biopharmaceutical companies.     

Countries in APAC are facing an increasing incidence of COVID-19. Accompanying the catastrophic loss of life that the virus has caused is the impact on the global economy, which has reeled from the effects of the pandemic. The COVID-19 pandemic has critically impacted the region; however, it has also provided an opportunity for stakeholders to realign their future path based on strategic intent and focus. COVID-19 has created an extraordinary emergency that is particularly affecting the supply chain. The supply chain disruptions, along with the enormous need for medical devices and protective health care material, have generated the need for new initiatives and the use of emerging technologies such as three-dimensional printing (3DP) to come forward and support health care professionals and supply chain. The COVID-19 pandemic has adversely impacted the region, but it has also provided an opportunity for stakeholders to realign their future path based on strategic intent and focus. India and China are the most preferred destinations for outsourcing, where a large pool of skilled labor is available at a lower cost. With increasing pressure to reduce manufacturing costs and accelerate time-to-market, many devices and diagnostics companies are looking to conduct clinical trial operations in APAC. Increasingly, third-party outsourcing service providers are playing a greater role in supporting and managing the delivery of key business functions like medical device development, sales and marketing, and regulatory compliance services in APAC.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC medical device and diagnostics contract research organization market. The APAC medical device and diagnostics contract research organization market is expected to grow at a good CAGR during the forecast period.
APAC medical device and diagnostics contract research organization market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

APAC Medical Device and Diagnostics Contract Research Organization Market Segmentation

APAC Medical Device and Diagnostics Contract Research Organization Market – By Type

  • Medical Devices
  • Diagnostics
    • Cardiac Biomarkers
    • Diabetes Management
    • Oncology
    • Infectious Diseases
    • Hematology
    • Chemistry and Immunoassays
    • Molecular Diagnostics
    • Others

APAC Medical Device and Diagnostics Contract Research Organization Market – By Services

  • Clinical Data Management
  • Monitoring
  • Clinical Project Management
  • Medical Writing
  • Clinical Auditing
  • Digital Health
  • Clinical Strategy
  • Others

APAC Medical Device and Diagnostics Contract Research Organization Market, by Country

  • Australia
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC  

APAC Medical Device and Diagnostics Contract Research Organization Market - Companies Mentioned

  • Charles River Laboratories, Inc
  • ICON PLC
  • IQVIA
  • Laboratory Corporation of America Holdings
  • North American Science Associates, Inc.
  • PAREXEL International Corporation
  • Qserve Group B.V.
  • WUXI APPTEC

Asia Pacific Medical Device and Diagnostics Contract Research Organization Report Scope

Report Attribute Details
Market size in 2021 US$ 2,394.72 Million
Market Size by 2028 US$ 4,110.91 Million
Global CAGR (2021 - 2028) 8.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Medical Devices
  • Diagnostics
By Services
  • Clinical Data Management
  • Monitoring
  • Clinical Project Management
  • Medical Writing
  • Clinical Auditing
  • Digital Health
  • Clinical Strategy
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Charles River Laboratories, Inc
  • ICON PLC
  • IQVIA
  • Laboratory Corporation of America Holdings
  • North American Science Associates, Inc.
  • PAREXEL International Corporation
  • Qserve Group B.V.
  • WUXI APPTEC
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    asia-pacific-medical-device-and-diagnostics-contract-research-organization-market-report-deliverables-img1
    asia-pacific-medical-device-and-diagnostics-contract-research-organization-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Type and Services

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    Australia, China, Japan, South Korea

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    1. Charles River Laboratories, Inc
    2. ICON PLC
    3. IQVIA
    4. Laboratory Corporation of America Holdings
    5. North American Science Associates, Inc.
    6. PAREXEL International Corporation
    7. Qserve Group B.V.
    8. WUXI APPTEC
    asia-pacific-medical-device-and-diagnostics-contract-research-organization-market-cagr